High-dose therapy for adult soft tissue sarcoma: Dose response and survival

被引：0
|
作者：
Elias, AD
机构：
[1] Dana Farber Canc Inst, Dept Internal Med, Div Med Oncol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
来源：
SEMINARS IN ONCOLOGY | 1998年 / 25卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：19 / 23
页数：5
相关论文
共 50 条
  • [21] High-dose chemotherapy in soft tissue sarcomas of adults
    Roy-Coquard, I
    Biron, P
    Blay, JY
    BULLETIN DU CANCER, 2001, 88 (09) : 858 - 862
  • [22] PHARMACOKINETICS OF HIGH-DOSE METHOTREXATE IN ADULT OSTEOGENIC-SARCOMA
    PIGNON, T
    LACARELLE, B
    DUFFAUD, F
    GUILLET, P
    CATALIN, J
    DURAND, A
    MONJANEL, S
    FAVRE, R
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 33 (05) : 420 - 424
  • [23] HIGH-DOSE DTIC IN ADVANCED SOFT-TISSUE SARCOMAS IN THE ADULT - A PHASE II STUDY OF THE EORTC SOFT-TISSUE AND BONE-SARCOMA-GROUP
    BUESA, JM
    MOURIDSEN, HT
    VANOOSTEROM, AT
    VERWEIJ, J
    WAGENER, T
    STEWARD, W
    POVEDA, A
    VESTLEV, PM
    THOMAS, D
    SYLVESTER, R
    ANNALS OF ONCOLOGY, 1991, 2 (04) : 307 - 309
  • [24] High-dose topotecan, thiotepa and melphalan (TTM regimen) with autologous stem cell support for adult metastatic soft tissue sarcoma
    Naparstek, E
    Harishanu, Y
    Rom, E
    Gipstein, L
    Aviv, F
    BONE MARROW TRANSPLANTATION, 2005, 35 : S258 - S259
  • [25] Perioperative high dose rate brachytherapy for soft tissue sarcoma
    Inoue, T
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2001, 31 (06) : 237 - 239
  • [26] High cumulative doxorubicin dose for advanced soft tissue sarcoma
    Tian, Zhichao
    Yang, Yang
    Yang, Yonghao
    Zhang, Fan
    Li, Po
    Wang, Jiaqiang
    Yang, Jinpo
    Zhang, Peng
    Yao, Weitao
    Wang, Xin
    BMC CANCER, 2020, 20 (01)
  • [27] High cumulative doxorubicin dose for advanced soft tissue sarcoma
    Zhichao Tian
    Yang Yang
    Yonghao Yang
    Fan Zhang
    Po Li
    Jiaqiang Wang
    Jinpo Yang
    Peng Zhang
    Weitao Yao
    Xin Wang
    BMC Cancer, 20
  • [28] High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group
    OS Nielsen
    P Dombernowsky
    H Mouridsen
    D Crowther
    J Verweij
    J Buesa
    W Steward
    S Daugaard
    M van Glabbeke
    A Kirkpatrick
    T Tursz
    British Journal of Cancer, 1998, 78 : 1634 - 1639
  • [29] High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group
    Nielsen, OS
    Dombernowsky, P
    Mouridsen, H
    Crowther, D
    Verweij, J
    Buesa, J
    Steward, W
    Daugaard, S
    van Glabbeke, M
    Kirkpatrick, A
    Tursz, T
    BRITISH JOURNAL OF CANCER, 1998, 78 (12) : 1634 - 1639
  • [30] RESPONSE TO ANGIOTENSIN II IN PATIENTS ON HIGH-DOSE VASOPRESSOR THERAPY IS ASSOCIATED WITH SURVIVAL
    Hammer, John
    DeMott, Sarah
    Russell, Christopher
    Taylor, Brice
    Heffner, Alan
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 629 - 629
12345